# Calcified chondroid mesenchymal neoplasm: a case report of perineal involvement and literature review

**Authors:** Chenxi Weng, Yuanli Zhong, Liqian Hu, Gangping Wang

PMC · DOI: 10.3389/fonc.2026.1783265 · Frontiers in Oncology · 2026-03-13

## TL;DR

This paper reports a rare case of a calcified chondroid mesenchymal neoplasm in the perineum, highlighting its unique features and possible broader occurrence.

## Contribution

The paper presents the first documented case of CCMN in the perineum, expanding the known locations of this tumor.

## Key findings

- CCMN was found in the perineum of a 59-year-old female, a location not previously reported.
- Molecular testing confirmed an FN1::FGFR2 gene fusion in the tumor.
- Immunohistochemical staining was not helpful for diagnosing CCMN.

## Abstract

Calcified chondroid mesenchymal neoplasm (CCMN) is a recently characterized solid tumor of bone and soft tissue. Its histological features include the formation of cartilage or chondroid matrix, while molecular characteristics are marked by the presence of FN1 gene rearrangement. This article presents a rare case of CCMN occurring in the perineum of a 59-year-old female. The tumor exhibits the following characteristics: grossly, it appears as a solid nodule; histologically, it demonstrates lobulated growth, with polygonal, oval, or spindle-shaped cells observed within the chondroid matrix, alongside a significant number of osteoclast-like giant cells and calcium phosphate-like deposits. Molecular testing confirmed the presence of an FN1 (exon 36)::FGFR2 (exon 2) gene fusion through RNA sequencing. Immunohistochemical staining did not provide substantial assistance in diagnosing CCMN. Although recurrence occurred post-surgical resection, it was not common. Currently, there are no reported cases of metastasis. Existing literature primarily identifies such tumors in the distal extremities and temporomandibular joint; however, the case reported herein is the first documented occurrence in the perineum of a female. This finding suggests that the spectrum of CCMN may extend beyond the traditionally recognized locations of the distal extremities and temporomandibular joint.

## Linked entities

- **Genes:** FN1 (fibronectin 1) [NCBI Gene 2335], FGFR2 (fibroblast growth factor receptor 2) [NCBI Gene 2263]

## Full-text entities

- **Genes:** FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, FGFR2 (fibroblast growth factor receptor 2) [NCBI Gene 2263] {aka BBDS, BEK, BFR-1, CD332, CEK3, CFD1}
- **Diseases:** metastasis (MESH:D009362), CCMN (MESH:D008949), tumor (MESH:D009369)
- **Chemicals:** calcium phosphate (MESH:C020243)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13021877/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13021877/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC13021877/full.md

---
Source: https://tomesphere.com/paper/PMC13021877